These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20478402)

  • 21. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Gisbert JL; Marcos S; Pajares JM
    Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
    Moayyedi P; Sahay P; Tompkins DS; Axon AT
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):835-40. PubMed ID: 8574714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin.
    Adamek RJ; Opferkuch W; Pfaffenbach B; Wegener M
    Am J Gastroenterol; 1996 Jan; 91(1):98-100. PubMed ID: 8561153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Helicobacter pylori infection.
    Costa F; D'Elios MM
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Helicobacter pylori isolates of dyspeptic Nigerian patients.
    Abdulrasheed A; Lawal OO; Abioye-Kuteyi EA; Lamikanra A
    Trop Gastroenterol; 2005; 26(2):85-8. PubMed ID: 16225052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
    Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection in pediatrics.
    Veres G; Pehlivanoglu E
    Helicobacter; 2007 Oct; 12 Suppl 1():38-44. PubMed ID: 17727459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of P-glycoprotein multidrug transporter activity measurement in patients with Helicobacter pylori infection.
    Babić Z; Kucisec-Tepes N; Troskot R; Dorosulić Z; Svoboda-Beusan I
    Coll Antropol; 2009 Dec; 33(4):1145-50. PubMed ID: 20102060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
    Lengyel G; Zsolt T
    Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication.
    Ahmed F; Murthy UK; Chey WD; Toskes PP; Wagner DA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):875-80. PubMed ID: 16225498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.
    Hathroubi S; Servetas SL; Windham I; Merrell DS; Ottemann KM
    Microbiol Mol Biol Rev; 2018 Jun; 82(2):. PubMed ID: 29743338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany.
    Wüppenhorst N; Lenze F; Ross M; Kist M
    J Antimicrob Chemother; 2011 Jan; 66(1):222-3. PubMed ID: 21051371
    [No Abstract]   [Full Text] [Related]  

  • 34. Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media.
    Bessa LJ; Grande R; Di Iorio D; Di Giulio M; Di Campli E; Cellini L
    APMIS; 2013 Jun; 121(6):549-60. PubMed ID: 23237527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine, a novel treatment for Helicobacter pylori infection.
    Huynh HQ; Couper RT; Tran CD; Moore L; Kelso R; Butler RN
    Dig Dis Sci; 2004; 49(11-12):1853-61. PubMed ID: 15628716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucolytics and Helicobacter pylori eradication.
    Guslandi M
    Helicobacter; 2003 Feb; 8(1):79; author reply 79-80. PubMed ID: 12603620
    [No Abstract]   [Full Text] [Related]  

  • 37. Helicobacter pylori diagnostics and treatment: could a lack of universal consensus be the best consensus?
    Couturier MR; Marshall BJ; Goodman KJ; Mégraud F
    Clin Chem; 2014 Apr; 60(4):589-94. PubMed ID: 23908455
    [No Abstract]   [Full Text] [Related]  

  • 38. Bifunctional Enzyme SpoT Is Involved in Biofilm Formation of Helicobacter pylori with Multidrug Resistance by Upregulating Efflux Pump Hp1174 (
    Ge X; Cai Y; Chen Z; Gao S; Geng X; Li Y; Li Y; Jia J; Sun Y
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance in
    Boyanova L; Hadzhiyski P; Kandilarov N; Markovska R; Mitov I
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):909-915. PubMed ID: 31424296
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of probiotics in Helicobacter pylori eradication therapy.
    Medeiros JA; Pereira MI
    J Clin Gastroenterol; 2013 Jan; 47(1):1-5. PubMed ID: 23222208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.